ÈÖ¹æ |
ɽÂê |
Í×Ìó |
ÂоݼÔÅù |
·ÇºÜ»ïÅù |
114 |
Effects of Lactoferrin on Oral and Throat Conditions under Low Humidity Environments: A Randomized, Double-Blind, and Placebo-Controlled Crossover Tria |
To evaluate the effects of a single ingestion of bovine lactoferrin (bLF) on oral and throat conditions under a low-humidity environment. A randomized, double-blind, 2-sequence, 2-treatment, and 2-period placebo-controlled crossover trial was conducted. Healthy adult subjects orally ingested bLF dissolved in water, or placebo water, followed by exposure to low humidity (20 ◦C, 20% relative humidity (RH)) for 2 h. The primary endpoint was subjective oral and throat discomfort assessed by a visual analog scale (VAS), which positively correlated with the discomfort. Secondary endpoints were unstimulated whole salivary flow rate (UWSFR) and salivary immunoglobulin A (IgA) secretion rate. Overall, 40 subjects were randomly assigned to two sequences (20 each) and 34 were analyzed.
The VAS values for oral and throat discomfort in the bLF treatment were significantly lower than in the placebo treatment, whereas UWSFR and IgA secretion rates were comparable between the two treatments. Adverse drug reactions were not observed. Subjective oral and throat discomfort associated with low humidity is suppressed by a single ingestion of bLF. Our findings demonstrate the novel use of bLF in a clinical situation that leverages its unique characteristics. |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
113 |
¥·¥ã¥ó¥×¡¼¤ª¤è¤Ó¥¹¥«¥ë¥×¥¨¥Ã¥»¥ó¥¹¤Î»ÈÍѤˤè¤ëƬȱ¤Ø¤Î¸ú²Ì¤Îɾ²Á |
¥·¥ã¥ó¥×¡¼¤ÈƬÈ饨¥Ã¥»¥ó¥¹¤Î»ÈÍÑÁ°¸å¤Ç¡¢µÒ´Ñɾ²Á¤È¤·¤ÆÌÓȱ·Â¤ª¤è¤ÓÌÓȱËÜ¿ô¤Î²òÀÏ¡¤¤Þ¤¿Àöȱ»þ¤ÎÈ´¤±ÌÓËÜ¿ô¤Î²òÀÏ¡¤¼ç´Ñɾ²Á¤È¤·¤Æ¥¢¥ó¥±¡¼¥È¤òÀßÄꤷɾ²Á¤ò¹Ô¤Ã¤¿¡£»î¸³À½Éʤϡ¢30ºÐ¤«¤é59ºÐ¤Þ¤Ç¤Î39¿Í¤Î·ò¹¯¤ÊÆüËÜ¿ÍÃ˽÷¤Ë24½µ´Ö»ÈÍѤȤ·¤¿¡£»ÈÍѸ塢ȱ¤ÎËÜ¿ô¡¢ÌÓȱ¤Îľ·Â¡¢¤ª¤è¤Ó¼ç´Ñɾ²Á¤¬Í°Õ¤Ë²þÁ±¤µ¤ì¤¿¡£¤³¤ì¤Ë¤è¤ê¡¢»î¸³À½ÉʤλÈÍѤ¬ÇöÌÓ¤äÈ´¤±ÌÓ¤Ë͸ú¤Ç¤¢¤ë¤³¤È¤¬¼¨º¶¤µ¤ì¤¿¡£ |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
112 |
Effects of high-fiber food product consumption and personal health record¡¡use on body mass index and bowel movemen |
|
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
111 |
Ç¥ÉؤËÂФ¹¤ë¥Ü¥Ç¥£ÍÑ¥¯¥ê¡¼¥à¤Î°ÂÁ´À¤ª¤è¤ÓÍÍÑÀ¤Î¸¡Æ¤ |
»î¸³³«»Ï»þ¤ÎÇ¥¿±½µ¿ô¤¬9¡Á32½µ¤ÎÇ¥ÉØ31̾¤òÂоݤˡ¢Ê¢Éô¤ËÊݼ¾¥¯¥ê¡¼¥à¤ò4½µ´ÖÏ¢ÁÛ¤µ¤»¤¿¤È¤³¤í¡¢³«»Ï»þ¤ÈÈæ³Ó¤·¡¢ÈéÉæ½ê¸«¤Î´¥Á祹¥³¥¢¤¬Í¥°Ì¤ËÄã²¼¤·¤¿¡£µ¡´ï¬Äê¤Ë¤ª¤¤¤Æ¤ÏÈéÉæ¿åʬÎ̬Äê¡¢Èé»éÎÌ¡¢ÈéÉæÃÆÎÏÀ¡¢ÈéÉæÌ©ÅÙ¡¢¿¿ÈéÌ©ÅÙ¤ª¤è¤ÓɽÈéÌ©ÅÙ¤ÎÍ°Õ¤ÊÁý²Ã¤¬¤ß¤é¤ì¤¿¡£¤Þ¤¿¡¢Í³²»ö¾Ý¤Ï1Îã¤â¤Ê¤¯Ëܻ¤Ç»ÈÍѤ·¤¿Êݼ¾¥¯¥ê¡¼¥à¤Ï°ÂÁ´À¤¬¹â¤¤¤³¤È¤¬³Îǧ¤µ¤ì¤¿¡£¤³¤ì¤é¤Î¤³¤È¤è¤ê¡¢Ç¥¿±Ãæ¤Ë¹â¤¤Êݼ¾ÎϤòͤ¹¤ë¥Ü¥Ç¥£ÍÑ¥¯¥ê¡¼¥à¤ò·Ñ³¤·¤Æ»ÈÍѤ¹¤ë¤³¤È¤Ï¡¢Ç¥ÉؤÎÈéÉæ¤ò·ò¤ä¤«¤ËÊݤĤ¿¤á¤ËÍÍѤǤ¢¤ë¤È¹Í¤¨¤é¤ì¤¿¡£ |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
110 |
¥Ö¥é¥··¿ÈþÍƵ¡´ï¤Î»ÈÍѤˤè¤ëµÓ¤Î·ìή²þÁ±¤Îɾ²Á |
20 ºÐ°Ê¾å60 ºÐ°Ê²¼¤Î½÷À¤òÂоݤˡ¤Äã¼þÇÈÈþÍƵ¡´ï¤òñ²ó»ÈÍѤ·¤¿ºÝ¤ÎµÓ¤Î·ìή¤ÎÊѲ½¤òɾ²Á¤·¤¿¡£¤½¤Î·ë²Ì¡¤±¦¤Õ¤È¤â¤â΢¤ÎÊ¿¶Ñ·ìήÎ̤¬Í°Õ¤Ë²þÁ±¤·¤¿¡£¤³¤Î¤³¤È¤«¤é¡¤È︳ÉʤλÈÍѤˤè¤ê¡¤µÓ¤Î·ì¹Ô¤¬Â¥¿Ê¤µ¤ì¡¤¤à¤¯¤ß¤Î·Ú¸º¤¬´üÂԤǤ¤ë¤È¹Í¤¨¤é¤ì¤¿¡£ |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
109 |
ÊØÈë¤òÁʤ¨¤ëÀ®¿Í½÷À¤òÂоݤȤ·¤¿·¬¤ÎÍÕÀĽÁÀݼè¤Ë¤è¤ëIJÆâ´Ä¶¤ª¤è¤ÓÈéÉ浡ǽ¤ËµÚ¤Ü¤¹±Æ¶Á |
ÊØÈë¤ÏIJÆâ´Ä¶¤Î°²½¤À¤±¤Ç¤Ï¤Ê¤¯¡¢ÍÍ¡¹¤Ê¼À´µ¤äÈéÉ浡ǽ¤Ë¤â±Æ¶Á¤òÍ¿¤¨¤ë¤³¤È¤«¤é¡¢ÊØÈë²þÁ±¤äIJÆâ´Ä¶²þÁ±¤Ø¤Î´Ø¿´¤¬¹â¤Þ¤Ã¤Æ¤¤¤ë¡£Ëܸ¦µæ¤Ç¤ÏÊØÈë¤òÁʤ¨¤ëÀ®¿Í½÷À¤Ë¡¢·¬¤ÎÍÕÊ´Ëö¤ò¼çÀ®Ê¬¤È¤·¤¿·¬¤ÎÍÕÀĽÁ¤ò1Æü3²ó¡¢2¤«·î·Ñ³Àݼ褵¤»¤¿¡£·¬¤ÎÍÕÀĽÁÀݼèÁ°¸å¤ÎIJÆâ´Ä¶¤òÈæ³Ó¤·¤¿·ë²Ì¡¢ÇÓÊزó¿ô¤¬Í°Õ¤ËÁý²Ã¤·¡¢Ä²ÆâºÙ¶ÝÁѤÎBifudobacterium¤ÈLactobacillales¤ÎÀêÍΨ¤¬Í°Õ¤ËÁý²Ã¤·¤¿¡£ÈéÉ浡ǽ¤Ë¤ª¤¤¤Æ¤Ï¡¢ÈéÉæÃÆÎÏÀ¤¬Í°Õ¤ËÁý²Ã¤·¤¿¡£°Ê¾å¤Î·ë²Ì¤è¤ê¡¢·¬¤ÎÍÕÀĽÁ¤ÎÀݼè¤ÏÎɹ¥¤Ê±Æ¶Á¤òµÚ¤Ü¤¹¤³¤È¤¬¼¨º¶¤µ¤ì¤¿¡£ |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
108 |
¥Ò¥·¥¨¥¥¹¤ª¤è¤Ó¥È¥Þ¥ÈÃê½Ðʪ´ÞÍ¥µ¥×¥ê¥á¥ó¥È¤ÎÀݼè¤Ë¤è¤ëÈ©¤ÎÊݼ¾À¡¤¹³Åü²½¡¤¹³¥«¥ë¥Ü¥Ë¥ë²½¤Ê¤é¤Ó¤Ë¹³»À²½¤Ë´Ø¤¹¤ëÎ×¾²»î¸³ |
Ëܻ¤Ç¤Ï¡¤20 ºÐ°Ê¾å 64 ºÐ°Ê²¼¤ÎÁ´¿È¤ÎÈéÉæ¤Î´¥Á硤ÈéÉæ¤Î¤¿¤ë¤ß¤ò¼«³Ð¤¹¤ë·ò¾ï¿ÍÃ˽÷¤òÂоݤȤ·¤Æ¡¤ÈéÉæ¿åʬ¾ø»¶Î̤ò»Øɸ¤È¤·¤¿Êݼ¾À¸þ¾å¤Ë¤è¤ë¥Ð¥ê¥¢µ¡Ç½²þÁ±¡¤¿§º¹·×¤äÈ©¾õÂÖ»£±Æ¤ò¤Ï¤¸¤á¤È¤¹¤ëÈ©¿§¤Ø¤Î±Æ¶Á¡¤AGEs ÃͤäÅü»À²½Êª¼Á¤ò»Øɸ¤È¤¹¤ë¹³Åü²½¡¤¹³¥«¥ë¥Ü¥Ë¥ë²½¡¤¹³»À²½¤ÎºîÍѤˤĤ¤¤Æ³Îǧ¤¹¤ë¤³¤È¤òÌÜŪ¤È¤·¤Æ¡¤¥Ò¥·¥¨¥¥¹¤ª¤è¤Ó¥È¥Þ¥ÈÃê½Ðʪ¤Î 12 ½µ´ÖϢ³Àݼè¤Ë¤è¤ë̵ºî°Ù²½Æó½ÅÌÕ¸¡¥×¥é¥»¥ÜÂоÈʹԷ²´ÖÈæ³Ó»î¸³¤ò¼Â»Ü¤·¤¿¡£
¡¡ÈéÉæ¿åʬ¾ø»¶ÎÌÄã²¼¤Ë¤è¤ëÈ©¤ÎÊݼ¾À¸þ¾å¤Ë¤è¤ëÈéÉæ¥Ð¥ê¥¢µ¡Ç½²þÁ±¸ú²Ì¡¤¿§º¹·×¤ª¤è¤ÓÈ©¾õÂÖ»£±Æ¤Ë¤è¤ëÈ©¿§¸þ¾å¸ú²Ì¤¬³Îǧ¤µ¤ì¤¿¡£¤Þ¤¿¡¤Åü²½¡¦¥«¥ë¥Ü¥Ë¥ë²½È¿±þʪ¼Á¤Ç¤¢¤ë¥Ú¥ó¥È¥·¥¸¥ó¸º¾¯¤Ë¤è¤ë¹³Åü²½ºîÍÑ¡¤¹³¥«¥ë¥Ü¥Ë¥ë²½ºîÍѤ¬Ç§¤á¤é¤ì¤¿¡£
¡¡¤µ¤é¤Ë¡¤°ÂÁ´À¤Ë´Ø¤·¤Æ¤âÉûºîÍÑ¡¤Í³²»ö¾ÝÄ´ºº¤Ë¤Ä¤¤¤Æ¡¤»î¸³´ü´ÖÃæ¤ËÌäÂê¤È¤Ê¤ë¤è¤¦¤Ê»ö¾Ý¤Ï³Îǧ¤µ¤ì¤Ê¤«¤Ã¤¿¡£
¡¡°Ê¾å¤Î¤³¤È¤«¤é¥Ò¥·¥¨¥¥¹¤ª¤è¤Ó¥È¥Þ¥ÈÃê½Ðʪ¥µ¥×¥ê¥á¥ó¥È¤ÎÀݼè¤Ë¤è¤ë¡¤¹³Åü²½ºîÍÑ¡¤¹³¥«¥ë¥Ü¥Ë¥ë²½ºîÍѤˤè¤êÈ©¿§¤ò¸þ¾å¤·ÈéÉæ¤Î¥Ð¥ê¥¢µ¡Ç½²þÁ±¡¤È©¤ÎÊݼ¾À¸þ¾å¤¬´üÂԤǤ¤ë¤³¤È¤¬ÌÀ¤é¤«¤È¤Ê¤Ã¤¿ |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
107 |
¼«³ÐŪ¤Ê¸ª¤³¤ê¾É¾õ¤Ë¤ª¤±¤ë¿´Íý¾õÂÖ¤ò¤Õ¤Þ¤¨¤¿¥¨¥¾¥¦¥³¥®¿©ÉʤαƶÁ |
Objevtives This study aimed to evaluate the effects of taking Acanthopanax Harms on the subjective sympton of shoulder muscle stiffness in assocication with mental conditions.
Method A before-after comparative study without placebo was conducted in 13 japanese male and female subjects aged betwwen 20 and 59 years and who had a subjective sympton of shoulder muscle stiffness. The subjects received Acanthopanax senticosus Harms at 24 tablets daily for 4 consecutive weeks. Shoulder muscle stiffness and mood state were evaluated by VAS scores and POMS scores, respectively, at baseline and at treatment weeks 2 and 4.
Result The VAS scores of 'shoulder muscle stiffness' and 'shoulder tention'significantry decreased at treatment week 4,compared to that at baseline. In adition , the POMS scores of 'Confusion' significantry decreased at treatment week 4. A significant negative correlation was obsereved between the decreased 'shoulder muscle stiffness' score and the POMS score of ''Vigor' at treatment week 4.
Conclution we showed that taking Acanthopanax senticosus Harms improved the subjectike sympton ofshoulder muscle stiffness,with mood state improvement suggested as the underlying fector. |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
106 |
¥ß¥ì¥Ã¥È¥¨¥¥¹, ¥Ñ¥ó¥È¥Æ¥ó»À¥«¥ë¥·¥¦¥à, L-¥·¥¹¥Á¥ó, ¥Ó¥ª¥Á¥ó´ÞÍ¿©ÉʤÎÀݼè¤Ë¤è¤ëÌÓȱ̩ÅÙ¤ª¤è¤ÓƬȱ¤Î³°´ÑÊѲ½¤Î¸¡¾Ú»î¸³ |
|
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
105 |
¥¨¥¤¥³¥µ¥Ú¥ó¥¿¥¨¥ó»À¡¦¥É¥³¥µ¥Ø¥¥µ¥¨¥ó»À´Þ͵ûÌý¤ÎÀݼè¤Ë¤è¤ë¼ê»ØËö¾¿Âβ¹¤Ø¤Î±Æ¶Áɾ²Á - ¥é¥ó¥À¥à²½¥×¥é¥»¥ÜÂоÈÆó½ÅÌÕ¸¡Ê¹Է²´ÖÈæ³Ó»î¸³ - |
|
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
104 |
Ç»½Ì¹È¹í¥«¥×¥»¥ë¤ÎÀݼè¤Ë¤è¤ë¥³¥ì¥¹¥Æ¥í¡¼¥ëÄ´Àá¸ú²Ì¤Îɾ²Á - ̵ºî°Ù²½Æó½ÅÌÕ¸¡¥×¥é¥»¥ÜÂоÈʹԷ²´ÖÈæ³Ó»î¸³ - |
|
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
103 |
¡Ö¥é¥¯¥È¥È¥ê¥Ú¥×¥Á¥É (VPP, IPP)¡×¤ò´Þͤ¹¤ë¥¿¥Ö¥ì¥Ã¥È¤ÎÀݼ褬·ò¾ï¼ãǯ¼Ô¤ÎÈèÏ«´¶¤ËµÚ¤Ü¤¹±Æ¶Á - ¥é¥ó¥À¥à²½Æó½ÅÌÕ¸¡¥×¥é¥»¥ÜÂоÈʹԷ²´ÖÈæ³Ó»î¸³ - |
|
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
102 |
¥Ò¥Ï¥ÄÃê½Ðʪ¤Î·ì°µ¤ËÂФ¹¤ëõº÷Ū¸¡Æ¤ |
|
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
101 |
¥Ò¥Ï¥ÄÃê½Ðʪ´ÞÍÊ´ËöÎÐÃã¤Î²á¾êÀݼè»þ¤Î°ÂÁ´À¤Î¸¡Æ¤ |
|
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
100 |
ÊÆæõ²ê¥¨¥¥¹ÇÛ¹çÊ´Ëöðùγ¤ÎÀݼè¤Ë¤è¤ëÁ´¿È¤ÎÈéÉæ¥Ð¥ê¥¢µ¡Ç½¤ËÂФ¹¤ë²þÁ±¸ú²Ì |
|
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
99 |
¾®»ù¤Ë¤ª¤±¤ë¥°¥í¥Ó¥óÃÁÇòʬ²òʪÇÛ¹ç¡Ö¥Ê¥Ã¥×¥ë(R)GD¡×12½µ´ÖÀݼè¤Î°ÂÁ´Àɾ²Á |
|
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
98 |
ËÜÂÖÀ¹â·ì°µ¾É¤Î¼£ÎŤˤª¤±¤ë¸åȯ°åÌôÉʤÎÎ×¾²Åª¸¡Æ¤-¥¢¥à¥í¥¸¥Ô¥óOD¾û¡Ö¥±¥ß¥Õ¥¡¡×¤ÎÍÍÑÀ- |
|
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
97 |
¥«¥Ä¥ª¥¨¥é¥¹¥Á¥ó´ÞÍ¥µ¥×¥ê¥á¥ó¥È¤Î¥Ò¥ÈÈ©¤ËÂФ¹¤ëÍÍÑÀ¸¡Æ¤ |
|
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
96 |
Clinical Utility of Erythrocyte Sedimentation Rate Test |
|
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
95 |
2·¿ÅüǢɴµ¼Ô¤Ë¤ª¤±¤ë¥Ô¥ª¥°¥ê¥¿¥¾¥ó¾û15mg¡Ö¥µ¥ï¥¤¡×¤ÎÎ×¾²ÅªÍÍÑÀ¤Î¸¡Æ¤ ¡½¥¢¥¯¥È¥¹(R)¾û15¤È¤ÎʹԷ²´ÖÈæ³Ó»î¸³¡½ |
|
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
94 |
Lactobacillus acidopilus L-92´ÞÍ¿©ÉÊÀݼè¤Ë¤è¤ë²ÖÊ´¾É;ɼԤËÂФ¹¤ë±Æ¶Á
¡½¥é¥ó¥À¥à²½¥×¥é¥»¥ÜÂоÈÆó½ÅÌÕ¸¡Ê¹Է²´Ö»î¸³¡½ |
Objevtives Several clinical trials have reported that oral administration of Lactobacillus acidophilus L-92(L-92) alleviated allergic symptoms. We,therefor,evaluated the effect of oralingestion of tablets containing L-92 on the symptoms of cedar pollen allergy.
Methods We conducted a randomized,double-blind,placebo-controlled parallel-groupstudy. Subjects were randomly divided into two groups,one group ingested two tablets containing 20.7mg of L-92 and other group ingested placebo tablets for 12 weeks.During this period,subjects assesed their nasal and ocular symptoms every day. These symptoms were scored from 0 (no symptom) to 4 (very severe). The severity of the symptoms was evaluated based on the scores which subjects assessed by themselves. Blood samples were used to determine the concentration of non-specfic IgE,anti-cedar IgE,and anti-cypress IgE.
Results Itchy eyes score,ocular symptom score and ocular symptom-medication score of L-92 group were significantly lower compared with the placebo group. The score for sneezing tended to be improved compared with the placebo group. Anti-cypress IgE level in L-92 group was reduced compared with the placebo group in the 12-weeks period.
Conclusion These results clearly suggest that oral administration of L-92 could alleviate the symptoms of pollen allergy. |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
93 |
¤³¤ó¤Ë¤ã¤¯¥»¥é¥ß¥É´ÞÍ¿©ÉʤÎÀݼè¤Ë¤è¤ëÈ©¤ÎÊݼ¾À¤ò¤Ï¤¸¤á¤È¤¹¤ëÈ©½ô¾É¾õ²þÁ±»î¸³
¡½Ìµºî°Ù²½Æó½ÅÌÕ¸¡¥×¥é¥»¥ÜÂоÈʹԷ²´ÖÈæ³Ó¡½ |
¤³¤ó¤Ë¤ã¤¯°òͳÍ襰¥ë¥³¥·¥ë¥»¥é¥ß¥É¡Ê¤³¤ó¤Ë¤ã¤¯¥»¥é¥ß¥É¡Ë1.8 mg ¤ò´Þ¤à¿©Éʤò¡¤12 ½µ´ÖËèÆüÀÝ¿©¤¹¤ë·ò¾ï¿Í»î¸³¤Ç¡¤ÈéÉæ¿åʬ¾ø»¶Î̤¬²þÁ±¤µ¤ì¤ëÊó¹ð¤Ï¤µ¤ì¤Æ¤¤¤ë¤¬¡¤ÄãÍÑÎ̤ǤÎÊó¹ð¤Ï¤Ê¤«¤Ã¤¿¡£¤½¤³¤Ç¡¤¤ï¤ì¤ï¤ì¤Ï¡¤¤³¤ó¤Ë¤ã¤¯¥»¥é¥ß¥É1 Æü0.6 mg¤È1.2 mg ¤òÀÝ¿©¤¹¤ë¥Ò¥È»î¸³¤ò¼Â»Ü¤·¤¿¡£¡¡35 ºÐ°Ê¾å59 ºÐ°Ê²¼¤ÎÈéÉæ¤Î´¥Á硤ȩ¹Ó¤ì¤ä¤¿¤ë¤ß¤ò¼«³Ð¤¹¤ë·ò¾ï¿ÍÃ˽÷¤òÂоݤȤ·¤Æ¡¤12 ½µ´Ö¤Î̵ºî°Ù²½Æó½ÅÌÕ¸¡¥×¥é¥»¥ÜÂоÈʹԷ²´ÖÈæ³Ó»î¸³¤Ë¤è¤ê¡¤È©¸¡ºº¡ÊÈéÉæ¿åʬÎÌ¡¤ÈéÉæ¿åʬ¾ø»¶ÎÌ¡¤ÈéÉæÃÆÎÏÀ¡¤ÈéÉæpH¡¤È©¿§Â¬Äꡤ³ÑÁزòÀÏ¡¤È©¾õÂÖ²òÀÏ¡¤¼«³Ð¾É¾õ¥¢¥ó¥±¡¼¥È¡¤ÈéÉæ²Ê°å¤Ë¤è¤ë½ê¸«¡Ë¤ò¹Ô¤Ã¤¿¡£
¡¡¤½¤Î·ë²Ì¡¤ÈéÉæ¿åʬ¾ø»¶Î̤κ¹Ê¬Ãͤ¬¡¤0.6 mg ÀÝ¿©·²¤Ç±¦頰Éô¤È±¦ÉªÉô¡¤¤µ¤é¤Ë1.2 mg ÀÝ¿©·²¤Ç¤Ï¡¤±¦頰Éô¤È¾åÇØÉô¡¤±¦ÂÇØÉô¤Ç¡¤¥×¥é¥»¥Ü·²¤ËÂФ·¤ÆͰդ˲þÁ±¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤¿¡£¤Þ¤¿¡¤¥¢¥ó¥±¡¼¥ÈÄ´ºº¤Ç¤â¡¤1.2 mg ÀÝ¿©·²¤Ç¡¤¡ÖÈ©¤Î½á¤¤¡×¤È¡ÖÈ©¤Î¥¥á¡×¤Î²þÁ±¤¬¼Â´¶¤Ç¤¤ë¤³¤È¤¬¼¨¤µ¤ì¤¿¡£¤µ¤é¤Ë¡¤°ÂÁ´À¤Ë´Ø¤·¤Æ¤âÉûºîÍÑ¡¤Í³²»ö¾ÝÄ´ºº¤Ë¤Ä¤¤¤Æ¡¤»î¸³´ü´ÖÃæ¤ËÌäÂê¤È¤Ê¤ë¤è¤¦¤Ê»ö¾Ý¤Ï³Îǧ¤µ¤ì¤Ê¤«¤Ã¤¿¡£¡¡¤³¤ó¤Ë¤ã¤¯¥»¥é¥ß¥É¤Ï¡¤1 Æü¤ÎÀÝ¿©Î̤¬0.6 mg¡¤1.2 mg ¤ÎÄãÍÑÎ̤Ǥ⡤ȩ¾õÂ֡ʥХꥢµ¡Ç½¤äÊݼ¾ºî
Íѡˤò²þÁ±¤·¡¤1.2 mg Àݼ跲¤Ç¤Ï¡¤¤½¤Î¸ú²Ì¤ò¼Â´¶¤Ç¤¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤¿¡£ |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
92 |
¥³¥é¡¼¥²¥ó¥Ú¥×¥Á¥ÉÀݼè¤ÎɨÄË·Ú¸ººîÍѤȰÂÁ´À¤Îɾ²Á |
Ʊ°Õ¼èÆÀ»þ¤ÎǯÎð¤¬45ºÐ°Ê¾å70ºÐ°Ê²¼¤ÎÆüËÜ¿ÍÃËÀ¤ª¤è¤Ó½÷À¤òÂоݤË,¥é¥ó¥À¥à²½¥×¥é¥»¥ÜÂоÈÆó½ÅÌÕ¸¡·²´ÖÈæ³Ó»î¸³¤È¤·,¸¡ºº»þ´ü¤ÏÀݼèÁ°,Àݼè4½µ¸å,8½µ¸å,12½µ¸å¤Î4²ó¤Ç,Àݼè´ü´Ö¤Ï84Æü´Ö¤È¤·¤¿¡£È︳¼Ô¤Ï56̾¤ÇËܻ¤ò³«»Ï¤·¤¿¤¬,ÅÓÃæ¤ÇÈ︳¿©ÉÊ·²3̾¤È¥×¥é¥»¥Ü¿©ÉÊ·²1̾¤¬¼«¸ÊÅÔ¹ç¤Ç¼Âष¤¿¤¿¤á,52̾¤¬²òÀÏÂоݤȤʤä¿¡£Ã˽÷Èæ,ǯÎð,¿ÈĹ,ÂνÅ,BMI,JKOM¹ç·×,JKOM VAS,KLʬÎà¤ÎÆâÌõ¤Ë¤Ï,»î¸³¿©ÉÊ·²´Ö¤Ç¤ÎÍ°Õº¹¤Ïǧ¤á¤é¤ì¤Ê¤«¤Ã¤¿¡£JKOM¤Ç¤Î¡µ¯¾²»þ¤Îɨ¤Î¤³¤ï¤Ð¤ê,¢Ê¿ÃϤǤÎɨÄË,£³¬Ãʾº¤ê»þ¤ÎɨÄË,¤Î©¤Ã¤Æ¤¤¤ë¤È¤¤ÎɨÄË,¥·ò¹¯¾õÂÖ¤È,¦·ò¹¯¾õÂ֤ؤΰ±Æ¶Á¤¬È︳¿©ÉÊ·²¤Î¤ß¤Ç²þÁ±¤·¤¿¤³¤È¤¬¼¨¤µ¤ì¤¿¡£·ë²Ì,È︳¿©ÉʤηѳŪÀݼ褬·ò¾ï¼Ô¤Îɨ¤ÎÄˤߤ䤳¤ï¤Ð¤ê¤ò·Ú¸º¤·¤Æɨ¾õÂÖ¤ò²þÁ±¤·,·ò¹¯Áý¿Ê¤ËƳ¤¯²ÄǽÀ¤¬¼¨¤µ¤ì¤¿¡£°ÂÁ´À¤ÎÌ̤ǤÏ,·ì±ÕÀ¸²½³Ø¸¡ºº¤Ï,Í°Õ¤ÊÊÑÆ°¤Î¤¢¤ë¹àÌܤò¤¢¤Ã¤¿¤¬,À¸ÍýŪÊÑÆ°¤ÎÈϰϤǤ¢¤Ã¤¿¡£Ç¢¸¡ºº¤Ï,¤¤¤º¤ì¤Î¹àÌܤˤâÊÑÆ°¤Ï¤Ê¤«¤Ã¤¿¡£¤Þ¤¿,ͳ²»ö¾Ý¤Ï³Îǧ¤µ¤ì¤Ê¤«¤Ã¤¿¡£ |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
91 |
·ò¾ï¼Ô¤òÂоݤȤ·¤¿Ç¾µ¡Ç½²þÁ±¤ËµÚ¤Ü¤¹¥×¥é¥º¥Þ¥í¡¼¥²¥óÀݼè¤Î±Æ¶Á¡¡¡½Ìµºî°Ù²½Æó½ÅÌÕ¸¡¥×¥é¥»¥ÜÂоÈʹԷ²´ÖÈæ³Ó¡½
|
To examine the effects of plasmalogen on brain function, a randomized double︱
blind placebo︱controlled parallel group comparison study was conducted with 50 to 70 years
old healty male and female who were aware of forgetfulness.
Methods¡¡Plasmalogens used in this study were prepared from chicken breast meat, and were
administered of low dose¡Ê1 mg plasmalogens╱day¡Ëto high dose¡Ê100 mg plasmalogens╱day¡Ë
for 12 weeks to subjects.
Results¡¡In Urbans neuropsychological test, significant scores were observed at the high dose
and low dose groups compared with 12 weeks after intake to before intake in the overall evaluation
item, respectively. Even in Cognitrax test, the score in some items increased significantly
compared with before to after intake. The safety of plasmalogens was confirmed, because no
adverse events were obserbed during this study.
Conclutions¡¡It can be said that plasmalogens derived from chicken beast meat can be safely
consumed in everyday diet and be expected to improve cognitive functions and prevent
alzheimer disease.
|
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
90 |
¥Ó¥ë¥Ù¥ê¡¼¥¨¥¥¹¥Ñ¥¦¥À¡¼´ÞÍ¥µ¥×¥ê¥á¥ó¥È¤ÎÀݼè¤Ë¤è¤ë»ëµ¡Ç½²þÁ±¸ú²Ì¤Î¸¡¾Ú
|
Verification of Improve Visual Effect Function by Intake of Bilberry Extract Powder Supplement. |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
89 |
¥ª¥ê¥´ÅüÊ´Ëö¤ÎÀݼè¤Ë¤è¤ëÊØÄ̲þÁ±¤Îɾ²Á¡¡¡ÝÆó½ÅÌÕ¸¡¥¯¥í¥¹¥ª¡¼¥Ð¡¼Ìµºî°Ù²½¥×¥é¥»¥ÜÈæ³Ó»î¸³¡Ý |
To evaluate the effect on bowel movements of ingesting a powdery supplement containing multiple oligosaccharides as a principal ingredient one package (5g in powder) once a day for two consecutive weeks for healthy male and female aged 20 to 59 years old who are mild constipation tendencies with 3 to 5 defecation frequency per week, a double-blind crossover randomized placebo-controlled comparative study was conducted. As a result of conducting a defecation survey (bowel movement and fecal property), improvement action of defecation amount and frequency was observed. There were no side effects or adverse events during the test period in adverse event survey, so the safety of powdery supplement containing multiple oligosaccharides as a principal ingredient was confirmed. |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
88 |
¥¢¥¹¥¿¥¥µ¥ó¥Á¥ó´ÞÍ¥«¥×¥»¥ëÀݼ褬·ò¾ïÀ®¿Í¤ÎÈ©¤ËÍ¿¤¨¤ëºîÍÑ |
30ºÐ°Ê¾å65ºÐ°Ê²¼¤Î»À²½¥¹¥È¥ì¥¹ÅÙ¤¬¹â¤¤·ò¾ïÃËÀ¤òÂоݤȤ·¤Æ¡¢ÄãÍÑÎÌ¡Ê3.57 mg¡Ë¤ËÀßÄꤷ¤¿¥¢¥¹¥¿¥¥µ¥ó¥Á¥ó´ÞÍ¥«¥×¥»¥ë¤ò4½µ´ÖϢ³Àݼ褵¤»¤¿ºÝ¤ÎÈ©¾õÂÖ¤ËÍ¿¤¨¤ëºîÍѤȰÂÁ´À¤Ë¤Ä¤¤¤Æ¸¡Æ¤¤¹¤ë¤³¤È¤òÌÜŪ¤È¤·¤Æ¡¢Ìµºî°Ù²½Æó½ÅÌÕ¸¡¥×¥é¥»¥ÜÂоÈʹԷ²´ÖÈæ³Ó»î¸³¤ò¼Â»Ü¤·¡¢È©¸¡ºº¡ÊÈéÉæ¿åʬÎÌ¡¢È©²èÁü²òÀÏÁõÃ֡ˤò¹Ô¤Ã¤¿·ë²Ì¡¢Êݼ¾À¡ÊÈ©¿åʬÎ̡˵ڤÓÈ©¤Î¡Ö¤¤á¡×²þÁ±ºîÍѤ¬ÆÀ¤é¤ì¤¿¡£¤Þ¤¿¡¢Í³²»ö¾ÝÄ´ººµÚ¤ÓÎ×¾²¸¡ººÃͤˤĤ¤¤ÆÄ´¤Ù¤¿½ê¡¢»î¸³´ü´ÖÃæ¤ËÉûºîÍѵڤÓͳ²»ö¾Ý¤â¤Ê¤¯¡¢Î×¾²¸¡ººÃͤˤª¤¤¤ÆÌäÂê¤È¤Ê¤ë¤è¤¦¤ÊÊÑÆ°¤Ï¤Ê¤«¤Ã¤¿¤³¤È¤«¤é¡¢¥¢¥¹¥¿¥¥µ¥ó¥Á¥ó´ÞÍ¥«¥×¥»¥ë¤Î°ÂÁ´À¤¬³Îǧ¤µ¤ì¤¿¡£¤Ê¤ª¡¢Ëܻ¤Î¼Â»Ü¤Ë¤«¤«¤ëÈñÍѤÏÉٻΥե¤¥ë¥à³ô¼°²ñ¼Ò¤¬Ééô¤·¤¿¡£ |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
87 |
¥Ô¡¼¥Á¥»¥é¥ß¥É¤Î²á¾êÎ̤ǤÎĹ´üÀݼè¤Ë¤è¤ë°ÂÁ´À¤Îɾ²Á |
²á¾êÎ̤ËÀßÄꤷ¤¿¥Ô¡¼¥Á¥»¥é¥ß¥É¤Î12½µ´ÖϢ³Àݼè¡Ê1Æü1¥«¥×¥»¥ë¡Ë¤·¤¿¤È¤¤Î°ÂÁ´À¤òÄ´ºº¤¹¤ë¤¿¤á¡¢20ºÐ°Ê¾å65ºÐ̤Ëþ¤Î·ò¾ï¤ÊÃ˽÷¤òÂоݤȤ·¤Æ¡¢¥ª¡¼¥×¥ó»î¸³¤ò¼Â»Ü¤·¡¢Íý³ØŪ¸¡ºº¡¢Î×¾²¸¡ººÃÍ¡¢¼«Â¾³Ð¾É¾õ¤ÎÍ¿¤¨¤ë±Æ¶Á¤Ë¤Ä¤¤¤ÆÄ´¤Ù¤¿½ê¡¢Íý³ØŪ¸¡ºº¡¢Î×¾²¸¡ººÃͤˤª¤¤¤ÆÌäÂê¤È¤Ê¤ë¤è¤¦¤ÊÊÑÆ°¤Ï¤Ê¤¯¡¢¤½¤Î¾¡¢»î¸³¿©¤Ëµ¯°ø¤¹¤ë¤è¤¦¤Êͳ²»ö¾Ý¤â³Îǧ¤µ¤ì¤Ê¤«¤Ã¤¿¤³¤È¤«¤é¡¢¥Ô¡¼¥Á¥»¥é¥ß¥É¤Î°ÂÁ´À¤¬ÌäÂê¤Ê¤¤¤³¤È¤¬³Îǧ¤µ¤ì¤¿¡£ |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
86 |
Effects of Collagen Tripeptide on Knee osteoarthritis in Humans and Animals. |
With the aim of determining the efficacy of collagen tripeptide(CTP) on knee osteoarthritis(OA), we conducted the following experiments: 1) assesment of CTP uptake into the arthrodial cartilage, 2) assessment of CTP administration into the arthrodial cartilage using knee OA model rabbits and 3) double-blind, placebo-controlled, randomised clinical trial in healthy human subjects. In the first experiment, the arthrodial cartilage exhibited high levels of radioactivity, demonstrating that the orally administered CTP was absorbed into the joint cartilage. In the model rabbits, the CTP-administered group had significantly milder symptoms in terms of cracks on the cartilage surface, cluster formation of cartilage cells and wear/loss of cartilaginous tissue. In the randomised control trial, CTP administration resulted in a significant improvement of hydrops and friction sounds. Furthermore, the subjects in whom CTP was administered tended to record better JKOM scores, confirming the improvement in QOL after the oral admistration of CTP. These results indicate the preventive/remedial effects of CTP on knee OA. |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
85 |
̵ºî°Ù²½Æó½ÅÌÕ¸¡Èæ³ÓË¡¤Ë¤è¤ë¥Ò¥Ï¥ÄÃê½Ðʪ´ÞÍÊ´ËöÎÐÃã¤ÎÀµ¾ï¹âÃÍ·ì°µ¼Ô¤Ê¤é¤Ó¤ËµÅÙ¹â·ì°µ¼Ô¤ËÂФ¹¤ëĹ´üÀݼè»þ¤Î·ì°µ¹ß²¼ºîÍѤª¤è¤Ó°ÂÁ´À¤Î¸¡¾Ú»î¸³ |
The efficacy and safety of powdered green tea containing long pepper extract for long term intake as a hypotensive agent was analyzed. The study, designed as a randomized double-blind placebo-controlled parallel-group study, was conducted in individuals with blood pressure in the high normal range and patients with first-degree hypertension. The subjects¡Î60 subjects╱group, 120 subjects in total ¡Êmale╱female¡á93╱27, age¡á26︱64 years old¡Ë¡Ïtook either the test tea¡Îpowdered green tea containing 150 mg of long pepper extract¡Êincluding 90¦Ìg of piperine¡Ë¡Ïor control tea¡Êplacebo; powdered green tea free of long pepper extract¡Ëonce daily for 12 weeks. We observed systolic and diastolic blood pressures, side effect, adverse event, laboratory test data, body weight, and heart rate. The test tea group showed a significant reduction of both the systolic and diastolic blood pressures compared to the placebo group at each time-point of evaluation from Week 1 onward. The results from the stratified analysis by baseline blood pressure classification showed similar to all subjects. No adverse reactions were seen in any of the groups during the study period. These results confirmed that powdered green tea containing long pepper extract exerts a sufficient reduction of both the systolic and diastolic blood pressures, beginning from early as 1 week after the start of intake. Also no safety problems were observed. So, powdered green tea containing long pepper extract is expected to contribute greatly to primary prevention of hypertension. |
Âоݼԡ¢¼çÍ×ɾ²Á¹àÌÜ¡¢Í¸úÀÀ®Ê¬ Åù |
·ÇºÜ»ï¡¢´¬¡¢¹æ Åù |
¢¥¥Ú¡¼¥¸¥È¥Ã¥× |